George H. D’Addamio
George H. D’Addamio, PhD, is President of PharmConsult, Inc., a consulting company in Atlanta, GA. During 8 years at SmithKline & French Laboratories (now Glaxo SmithKline), Dr. D’Addamio was responsible for preparing protocols, case report forms, integrated study reports, and regulatory submissions in Clinical R&D and Medical Affairs. As Scientific Manager, Clinical R&D, he was responsible for coordinating clinical research programs in Canada, Latin America, and the Pacific conducted under the US IND. In Medical Affairs, he managed operational groups responsible for medical writing, clinical monitoring, and safety reviews and quality control checks of CRFs. After leaving SK&F, Dr. D’Addamio worked for a CRO for 1.5 years before forming PharmConsult in 1987. Previous consulting experience includes project management, data management, statistical services, and medical writing. Currently, PharmConsult specializes in preparation of clinical development documents in various therapeutic areas for domestic and foreign pharmaceutical companies.
Kathi Durdon is Executive Director of the Central New York Biotech Accelerator (CNYBAC) located in Syracuse, NY managing facility operations; pharmaceutical, biologic and medical device client needs; and collaborative partnership programs. Kathi serves as a Board Member for both MedTech, a non-profit trade organization, and the Business Incubator Association of New York State (BIANYS) and is an Adjunct Assistant Professor at Upstate Medical University. Previously, Kathi was the Clinical Affairs Manager at Welch Allyn, a medical device manufacturer (now Hillrom), and Director of Clinical Trials at Upstate Medical University.